SEMA3A and neoplasm: Hu et al. [17] demonstrated up-regulation of Sema3A in metastatic cell lines, and from patients with tumor recurrence, leading to the conclusion that Sema3A promoted cell proliferation, cell migration, and invasion; moreover, survival analysis indicated that Sema3A can be an independent predictor of survival, and potential target for treatment [8].